On 13th August 2012, India opened a $12 million, government-backed laboratory whose mission is to create a new vaccine against HIV. The HIV Vaccine Translational Research Laboratory, which aims to recruit about 30 scientists, is embedded within the Translational Health Science and Technology Institute, a $200 million facility under development on the outskirts of New Delhi. It will work in collaboration with the New York based-International AIDS Vaccine Initiative (IAVI); operating costs will be shared equally.

There has always been a debate if there is an overuse of blood products. The resulting overuse of blood is problematic, and may do worse, if given transfusions prematurely or unnecessarily.On the other hand, it has also been experienced that in patients who undergo major surgeries, specially cardiac surgery, severe perioperative bleeding is seen.